Abstract
Patients with early rheumatoid arthritis (RA) usually are treated initially with synthetic disease-modifying antirheumatic drugs (DMARDs), preferably
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
